Cooccurring JAK2 V617F and R1063H mutations increase JAK2 signaling and neutrophilia in myeloproliferative neoplasms
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F18%3A73590410" target="_blank" >RIV/61989592:15110/18:73590410 - isvavai.cz</a>
Alternative codes found
RIV/68378050:_____/18:00502682 RIV/00023736:_____/18:00012484
Result on the web
<a href="http://www.bloodjournal.org/content/bloodjournal/132/25/2695.full.pdf" target="_blank" >http://www.bloodjournal.org/content/bloodjournal/132/25/2695.full.pdf</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1182/blood-2018-04-843060" target="_blank" >10.1182/blood-2018-04-843060</a>
Alternative languages
Result language
angličtina
Original language name
Cooccurring JAK2 V617F and R1063H mutations increase JAK2 signaling and neutrophilia in myeloproliferative neoplasms
Original language description
Clinical consequences of driver mutations in myeloproliferative neoplasms (MPNs) are well established, yet little is known about the impact of co-occurring JAK2 variants on the phenotype of MPNs. We tested a cohort of 390 JAK2 V617F-positive MPN patients for JAK2 R1063H, a variant previously described in polycythemia vera and hereditary erythrocytosis. We identified 14 carriers of both JAK2 V617F and JAK2 R1063H mutations. These patients exhibited significantly higher rate of neutrophilic granulocytosis compared to those harboring JAK2 V617F only. Quantification of R1063H allele in the genomic DNA samples indicated that the variant was inherited in 8 cases, with an allele burden around 50%. In 3 other patients with high JAK2 V617F allelic burden, the JAK2 R1063H was nearly homozygous (>80%), suggesting the acquisition of the second allele by uniparental disomy. In 3 patients the R1063H mutation was acquired (allele percentage between 20.7% - 31.5%). Our functional studies demonstrated that the JAK2 V617F-induced signaling via the dimeric myeloid cytokine receptors is increased in the presence of the R1063H when the two mutations are in cis. Thus, acquisition of V617F in cis on a germline R1063H allele, or an acquisition of additional R1063H mutation increases JAK2 V617F oncogenic signaling that promotes neutrophilia.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30205 - Hematology
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2018
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
BLOOD
ISSN
0006-4971
e-ISSN
—
Volume of the periodical
132
Issue of the periodical within the volume
25
Country of publishing house
US - UNITED STATES
Number of pages
5
Pages from-to
2695-2699
UT code for WoS article
000453926500012
EID of the result in the Scopus database
2-s2.0-85058788204